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Postoperative painAbstract Peripheral nerve blocks (PNBs) are increasingly used as a component of multimodal analgesia and
may be administered as a single injection (sPNB) or continuous infusion via a perineural catheter (cPNB).
We undertook a qualitative review focusing on sPNB and cPNB with regard to beneﬁts, risks, and opportu-
nities for optimizing patient care. Meta-analyses of randomized controlled trials have shown superior pain
control and reductions in opioid consumption in patients receiving PNB compared with those receiving in-
travenous opioids in a variety of upper and lower extremity surgical procedures. cPNB has also been asso-
ciated with a reduction in time to discharge readiness compared with sPNB. Risks of PNB, regardless of
technique or block location, include vascular puncture and bleeding, nerve damage, and local anesthetic sys-
temic toxicity. Site-speciﬁc complications include quadriceps weakness in patients receiving femoral nerve
block, and pleural puncture or neuraxial blockade in patients receiving interscalene block. The major limi-
tation of sPNB is the short (12-24 hours) duration of action. cPNBmay be complicated by catheter obstruc-
tion, migration, and leakage of local anesthetic as well as accidental removal of catheters. Potential
infectious complications of catheters, although rare, include local inﬂammation and infection. Other consid-
erations for ambulatory cPNB include appropriate patient selection, education, and need for 24/7 availability
of a health care provider to address any complications. The ideal PNB technique would have a duration of
action that is sufﬁciently long to address the most intense period of postsurgical pain; should be associated⁎ Corresponding author at: 4350 East-West Hwy Suite 430, Bethesda, MD 20814. Tel.: +1 240 821 9663; fax: +1 240 821 1296.
E-mail address: scorman@pharmerit.com (S.L. Corman).
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525Peripheral nerve block challenges and opportunitieswith minimal risk of infection, neurologic complications, bleeding, and local anesthetic systemic toxicity;
and should be easy to perform, convenient for patients, and easy to manage in the postoperative period.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Multimodal analgesia refers to the use of combinations of
analgesics acting via different mechanisms and thus taking ad-
vantage of additive or synergistic activity while minimizing
adverse events with larger doses of a single analgesic [1].
Evidence-based multimodal techniques are procedure speciﬁc
and may include combinations of systemic analgesics (eg, opi-
oids, acetaminophen, nonsteroidal anti-inﬂammatory drugs),
neuraxial analgesia (spinal, epidural, and combination spinal/
epidural), local inﬁltration, and peripheral nerve blocks
(PNBs).
The beneﬁts of PNBs are numerous and include improve-
ment in clinical, economic, and humanistic outcomes (Table 1).
PNBs have been associated with improvement in postopera-
tive pain control and reduction in the use of opioids in a variety
of surgical procedures [2-7]. Avoidance of opioids not only
minimizes the risk of adverse events but also has important
public health implications given that opioids prescribed at
hospital discharge, which are often in excess of the amount
required to manage postoperative pain, may serve as a
source for diversion [8,9]. Other beneﬁts of PNBs include
reduction in hospital resource utilization [10,11], improved
postoperative recovery [10,12,13], and improvement in patient
satisfaction [2].
Given the many beneﬁts of PNBs in practice, it is not sur-
prising that their use has expanded over the last several de-
cades. PNBs are now a common component of analgesia for
both upper extremity (eg, brachial plexus block using intersca-
lene, supra- or infraclavicular, and axillary nerve approaches)
[14] and lower extremity (eg, lumbar plexus, femoral, sciatic,
and popliteal sciatic blocks, among others) procedures [15].
Technical advances include the use of ultrasound-guided nee-
dle placement and the movement from the use of single injec-
tions of local anesthetic (single-shot PNB [sPNB]) to aTable 1 Beneﬁts of PNB as a component of multimodal post-
operative analgesia regimen
• Improvement in postoperative pain control and reduction in
the use of opioids [2-7]
• Reduction in hospital length of stay [10,11]
• Prevention of hospital readmissions [16]
• Reduction in postoperative nausea and vomiting [2]
• Faster movement to phase 2 recovery and/or postanesthesia
care unit bypass [13]
• Earlier participation in physical therapy [10]
• Improved patient satisfaction [2]continuous infusion administered using a perineural catheter
(continuous PNB [cPNB]). One recent study showed that the
use of femoral nerve block (FNB, both cPNB and sPNB) after
total knee arthroplasty (TKA) among Medicare patients in-
creased dramatically between 2008 and 2009 [16]. As this
use has expanded both within the hospital and in ambulatory
settings, a greater understanding of the potential risks of these
procedures and unmet needs has been achieved.
The objective of this article is to review the recent literature
on sPNB and cPNB as a component of multimodal postopera-
tive analgesia, highlighting beneﬁts, risks, and opportunities
for optimizing patient care. A search of the literature was per-
formed using PubMed, including citations published up to
March 2015. Search terms included nerve block [MeSH term],
combined with efficacy or effectiveness, safety or complication
or adverse event, and cost or economic. From the search re-
sults and the references cited in articles identiﬁed in the search,
we selected articles most relevant to our objective. The assess-
ment of efﬁcacy focused on systematic reviews and meta-
analyses comparing sPNB and cPNB to opioid-based analge-
sia and to each other. Additional information on risks and
complications was gathered primarily from PNB registries
and retrospective database analyses, which represent the use
of PNB in current clinical practice.2. Clinical efﬁcacy of PNB
2.1. PNB vs opioids
The efﬁcacy of sPNB in improving short-term pain control
has been shown in a number of upper and lower extremity sur-
gical procedures. In a Cochrane review of randomized trials in
patients undergoing major knee surgery, PNB used in combi-
nation with systemic analgesics (primarily opioids) was asso-
ciated with signiﬁcantly lower pain scores at rest from 0 to
72 hours after surgery, but no difference in pain on movement
until 48 to 72 hours postoperatively, compared with systemic
analgesics alone [6]. This review included a broad range of
surgical procedures (TKA, anterior cruciate ligament [ACL]
repair, and meniscectomy), block techniques (sPNB and
cPNB), and locations (femoral, femoral/sciatic, adductor ca-
nal), many of which have been investigated in more focused
systematic reviews. Ameta-analysis of randomized trials com-
paring single-shot FNB to intravenous patient-controlled anal-
gesia opioids showed a signiﬁcant reduction in pain at rest and
onmovement for up to 24 and 48 hours, respectively, with sig-
niﬁcantly less opioid consumption for up to 48 hours [2].
When continuous FNB was compared with intravenous
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ment were signiﬁcantly reduced for 48 and 72 hours, respec-
tively [2]. In a meta-analysis comparing single and
continuous psoas compartment block to oral opiates in patients
undergoing total hip arthroplasty, visual analogue scale pain
scores was signiﬁcantly reduced in patients receiving either
type of psoas compartment block at up to 24 hours postopera-
tively [3]. Pain outcomes were not reported for any subsequent
time points. One retrospective study found a signiﬁcantly low-
er 30-day all-cause readmission rates in Medicare patients un-
dergoing TKA with cPNB (hazard ratio = 0.43, P b .001) or
sPNB (hazard ratio = 0.49, P b .001) compared with no
PNB; 90-day and 365-day readmission rates were also signif-
icantly reduced [16].
The impact of PNB on pain intensity in patients undergoing
ACL repair is not as clear. In a Cochrane review comparing
PNB in combination with systemic analgesia to systemic anal-
gesia alone (n = 3 randomized controlled trials), pain intensi-
ties at rest and on movement were not signiﬁcantly improved
in patients undergoing ACL repair receiving PNB [6]. In a sys-
tematic review of 13 randomized trials comparing FNB to
sham or placebo blocks in patients undergoing ACL surgery,
Mall and Wright [17] found that pain relief was greater with
FNB in only 5 trials and that opioid-related nausea and seda-
tion occurred less frequently in the FNB group in only 1 trial.
Differences in study designs and outcomes have largely
prevented studies of upper extremity surgical procedures to
be combined using meta-analysis [4]; however, several sys-
tematic reviews have provided qualitative summaries of the
existing evidence. In a review of trials comparing single-shot
and continuous interscalene block (ISB) to saline injection or
opioids for shoulder surgery, pain control was superior with
single-shot ISB for up to 24 hours in 4 of 4 trials and with con-
tinuous ISB for up to 48 hours in 2 of 2 trials [18]. A more re-
cent review focusing on arthroscopic shoulder surgery
reported that all of the 10 studies included found signiﬁcant re-
ductions in pain for up to 24 hours after surgery, with signiﬁ-
cant reductions in opioid use seen in 8 of 9 studies reporting
this outcome [7].2.2. cPNB vs sPNB
Administration of local anesthetics via continuous infusion
allows for a duration of analgesia signiﬁcantly longer than that
of a single injection. In a pooled analysis of 21 studies compar-
ing cPNB to sPNB for postoperative analgesia, worst visual
analogue scale pain scores and pain at rest were signiﬁcantly
lower in patients receiving cPNB on postoperative days 0, 1,
and 2 but not day 3 [19]. Opioid consumption was also signif-
icantly reduced in the cPNB group on days 1 and 2.
The availability of cPNB has allowed for appropriate pa-
tients to be discharged home with an ambulatory infusion
pump rather than stay in the hospital or receive alternative an-
algesics (eg, oral opioids) at home. In 3 similarly designed tri-
als in patients undergoing TKA, total hip arthroplasty, or totalshoulder arthroplasty, Ilfeld and colleagues [20-22] found that
readiness for hospital discharge, as measured by adequate an-
algesia, not requiring IV opioids, and ability to walk at least 30
m, was achieved signiﬁcantly faster among patients receiving
cPNB until postoperative day 4 compared with those receiving
cPNB until the morning after surgery.3. Risks and limitations of PNB
Potential risks of PNB, regardless of technique or block lo-
cation, include vascular puncture and bleeding, nerve damage,
and local anesthetic systemic toxicity (LAST). PNB placement
using ultrasound guidance has been shown to reduce the inci-
dence of vascular puncture [23]. Neurologic complications are
of particular concern because the duration of symptoms can
extend for weeks or months after surgery [24,25]. These
events are typically described by patients as tingling, pain on
pressure, or pins and needles, and are associated with both
sPNB and cPNB [24]. The incidence has been reported to be
as high as 8.2% [26], with mixed evidence regarding the rela-
tive risk with sPNB vs cPNB. One study showed a higher in-
cidence with sPNB vs cPNB in patients receiving femoral
blocks [24], one showed no difference in risk among a popula-
tion receiving PNB at various locations [26], and one showed
higher rates of neurological complications lasting at least
6 months with cPNB, although this difference did not reach
statistical signiﬁcance (P = .08) [27]. Rates of long-term neu-
rologic symptoms have been shown to be higher in patients re-
ceiving ISBs (3.5% vs 0.5%with other blocks, P = .002) [27].
Signs and symptoms of LAST are dose dependent and
range from metallic taste, tinnitus, and perioral numbness to
seizure, cardiac arrest, and death [28]. Registry-based studies
that included either exclusively or primarily sPNB have report-
ed seizure incidence of 0.08 to 0.28 case per 1000 blocks
[27,29,30], whereas studies evaluating exclusively cPNB have
found no cases of seizure [25,31]. Because of signiﬁcant over-
lap in the range of incidence, it is difﬁcult to determine wheth-
er seizure risk is reduced with cPNB. LAST without seizure is
reported at rates of 0.25%-0.9% in patients receiving cPNB
[25,31].
Site-speciﬁc limitations of PNBs include quadriceps weak-
ness in patients receiving FNB, which may increase risk of
falls, although this is controversial. Retrospective studies have
found no increased risk of falls in patients undergoing TKA
with PNB [16,32,33]. However, in a pooled analysis of 3 ran-
domized, placebo-controlled trials, patients with lower ex-
tremity cPNB with ropivacaine had signiﬁcantly more falls
than patients receiving perineural saline (7% vs 0%; P =
.013) [34]. In a meta-analysis of 5 studies comparing fall risk
among patients receiving lumbar plexus (either femoral or
psoas) cPNB to sPNB or no PNB, cPNB was associated with
a nearly 4-fold increase in the risk of falls [35]. However, the
authors note that avoiding the use of cPNB is unlikely to elim-
inate the risk of falls and may have a negative impact on pain
Table 2 Infection-related complications of continuous PNB
[46,48]
Complication Incidence from
observational
studies
Notes
Colonization
Inﬂammation
Infection
6%-69%
3%-9.6%
0%-3%
Most common organisms are
coagulase-negative Staphylo-
coccus; others include gram-
negative bacilli, including
Escherichia coli and Entero-
coccus, and S aureus.
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2197 patients undergoing primary TKA found an overall fall
rate of 2.7%; independent risk factors for falls included contin-
uous FNB (4.4; 95% conﬁdence interval [CI], 1.04-18.2), in-
creased age (odds ratio, 1.04; 95% CI, 1.0-1.07), and body
mass index N30 kg/m2 (2.4; 95% CI, 1.3-4.5) [36]. Single-
shot FNBwas not associated with an increased risk of fall. Ad-
ductor canal blocks are associated with less quadriceps weak-
ness [37-39], greater ability to ambulate [40,41], and similar
pain control compared with FNB in patients undergoing
TKA [38-41]; however, it is not yet clear whether these differ-
ences directly impact fall risk.
Upper extremity PNBs may be complicated by pleural
puncture and central neuraxial needle placement [18]. Pneu-
mothorax has been recently reported in 0.2% of patients re-
ceiving continuous ISB [42]. In a systematic review of 13
prospective and retrospective studies in patients receiving
ISBs, Moore and colleagues [43] reported that adverse effects
including dyspnea, hoarseness, Horner syndrome, and failed
block occurred in 8.14% of patients. However, a retrospective
analysis of 17 157 patients undergoing total shoulder arthro-
plasty found no increase in the risk of pulmonary complica-
tions or need for mechanical ventilation among patients
receiving ISB in combination with general anesthesia com-
pared with general anesthesia alone [44].
3.1. Single-shot PNB
The major limitation of sPNB is the short duration of action
of most local anesthetics. As such, sPNB is best suited for surgi-
cal procedures in which postoperative pain is not expected to ex-
ceed 12-24 hours in duration; otherwise, patients are at risk for
signiﬁcant rebound pain after discharge [45]. Administration
of larger volumes or higher concentrations of local anesthetics
may increase the duration of block but also increase the risk of
motor block and LAST [45]. Thus, alternative methods of
overcoming these limitations for surgical procedures with pain
persisting past the ﬁrst postoperative day are required.3.2. Continuous PNB
The incidence of cPNB complications is highly dependent
on the insertion technique and block location, and thus, it is
difﬁcult to make generalizations across studies. Minor compli-
cations include catheter dislodgement, obstruction, and ﬂuid
leakage at the catheter site [46]. Rates of catheter dislodgment
in studies of volunteers engaging in activities of daily living
were as high as 25% [47]. One study found that 2 of the 9 pa-
tients with dislodged interscalene catheters were readmitted to
the hospital, with the remaining 7 patients experiencing no sig-
niﬁcant pain [42].
Although rates of catheter bacterial colonization appear
high, clinically relevant infection is rare (Table 2) [46]. Risk
factors for colonization among patients receiving ultrasound-
guided catheter insertion include catheter duration N48 hours,diabetes, and antibiotic administration during the month prior
to surgery [48]. In contrast, single-injection PNB conducted
under ultrasound guidance has not been associated with
infection [49].
The costs associated with cPNB are an important consider-
ation for providers and hospitals implementing this technique.
These costs include infusion pumps, catheters, and other sup-
plies; local anesthetic medications; and provider time required
for patient education and follow-up. Sites using cPNBmay re-
alize cost savings with the use of reusable vs disposable pumps
and using ﬁxed-rate, basal-only pumps compared with
variable-rate, bolus-capable pumps [50]. Ultrasound-guided
sciatic cPNB has been shown to be more cost-effective than
nerve stimulation guidance for catheter placement, with an in-
crease in equipment costs being offset by a reduction in post-
operative nursing time [51].
Whether cPNB is used in an inpatient or ambulatory set-
ting, the resources required to provide this therapy safely and
effectively are substantial. Facilities implementing cPNB pro-
grams must ﬁrst invest in developing the appropriate infra-
structure (policies and protocols, communication channels)
and then commit resources to patient and provider education
and follow-up to ensure the best possible outcomes for pa-
tients. Practical considerations for home use of cPNB include
appropriate patient selection, follow-up, and education on
pumpmanagement and removal. Patients for whom ambulato-
ry cPNBmay be inappropriate include those with known renal
and hepatic insufﬁciency [52], heart and/or lung disease
(among patients with ISBs) [52], altered mental status or psy-
chosocial issues [53], inability to be contacted after discharge
or to access a medical facility in case of emergency [45], and
unwillingness to accept responsibility for pump management
[52]. Prior to discharge, patients must be educated on the ap-
propriate care of the catheter site and dressing, when to stop
the pump for signs of toxicity, how to troubleshoot any cathe-
ter or pump issues, when to call the physician or nurse for
signs of infection or problemswith the infusion system, and in-
structions for catheter removal [53,54]. Ambulatory cPNB
protocols differ in the frequency and mode of contact with pa-
tients after discharge, ranging fromwritten instructions only to
home nursing visits [55], and the appropriate strategy should
be determined on a case-by-case basis with consideration for
the type of surgery and patient characteristics. Regardless of
528 G. Joshi et al.planned follow-up, however, a health care provider is required
to be available 24 hours per day, 7 days per week to address
patient concerns and questions. Catheter removal can usually
be performed by the patient or a caregiver [45].4. Opportunities
The ideal PNB technique would have a duration of action
sufﬁcient to provide pain relief for the most intense period of
postoperative pain but not result in a dense motor block that
could be unpleasant to the patient or lead to safety issues such
as falls. Moreover, the risk of infection, neurologic complica-
tions, bleeding, and LAST should be minimized to the extent
possible. The technique should be easy to perform and thus in-
dependent of the technical skill of the anesthesiologist and
with minimal chance of failed procedures. Finally, the ideal
PNB technique should be convenient for patients and easy to
manage in the postoperative period.
Currently available PNB techniques fall short of this ideal
in a number of ways. sPNB is simple to perform, avoids the
concerns associated with indwelling cPNB catheters, and does
not require the patient to be responsible for medication admin-
istration at home, but the duration of block is often insufﬁcient
to manage pain beyond the ﬁrst postoperative day. cPNB has
the advantages of a prolonged duration of analgesia while ad-
ministering more dilute local anesthetic solutions (and thus
minimizing risk of LAST). However, catheter dislodgement
rates may be unacceptable, not all patients are willing to accept
the responsibility of home cPNB, and extensive education and
follow-up are required for successful use.5. Discussion
Peripheral nerve block techniques are now commonly incor-
porated into multimodal postoperative analgesic strategies. The
consequences of expanded use of PNB include improvement in
pain relief and postoperative opioid requirements, in addition to
improved postoperative recovery and fewer opioid-related ad-
verse events. As an extension of these beneﬁts, patients are able
to be discharged from the hospital earlier, and surgical proce-
dures are able to be performed in outpatient settings.
Despite these advances, there is room for improvement in
the provision of postoperative pain management. Although
cPNB addressed the primary limitation of sPNB, it has intro-
duced a new set of technical difﬁculties, patient education
needs, and complications. For carefully selected patients and
well-trained anesthesiologists, cPNB can be a safe and effec-
tive postoperative pain management strategy. Unfortunately,
the increased complexity associated with an indwelling cathe-
ter and pump assembly increases the likelihood of technique
failure (ie, catheter dislodgement, kinking, or leaking), and
there are many patients for whom cPNB is not appropriate ei-
ther because of comorbid conditions, logistical issues, orunwillingness to participate in management. Additional PNB
modalities are needed to reach this population, in addition to
minimizing risks of complications and costs among patients
who are cPNB candidates.Acknowledgments
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